Αρχική World News New on NCI’s Websites for September 2021

New on NCI’s Websites for September 2021

, by NCI Staff

NCI’s collection of cancer information products is constantly growing, so we provide periodic updates on new and updated content of interest to the cancer community.

NCI Annual Plan & Budget Proposal for Fiscal Year 2023

Each year, NCI prepares a plan for advancing cancer research and proposes the budget required to fund a broad research portfolio, support the cancer research workforce, and sustain the infrastructure that enables rapid progress against cancer. 

The NCI Annual Plan & Budget Proposal for Fiscal Year 2023 opens with a message from NCI Director Norman Sharpless, M.D., who writes that the advances made since the National Cancer Act of 1971 was signed into law have led us into a golden age of cancer research. The Fiscal Year 2023 plan highlights four areas of scientific opportunity that, with further investment, NCI believes will catalyze progress against cancer: 

•    improving cancer clinical trials
•    designing drugs with computer-based approaches 
•    preventing cancer with precision medicine
•    understanding tumor dynamics

Stories to Commemorate 50 Years of the National Cancer Act

The stories of the National Cancer Act’s impact are inspirational and educational, and they provide an opportunity to learn about the pioneers who have helped move cancer research and cancer care forward. The collection includes stories on people who have benefited from advances in treatment and care, such as Emily Whitehead, the first child in the world to receive CAR T-cell therapy, and about some of the researchers responsible for discoveries that have fundamentally changed our understanding of cancer.  

NCI’s Cancer Community Partnership

NCI’s Cancer Community Partnership was created by the NCI Center for Cancer Training to connect the scientific and medical communities with people personally affected by cancer. The partnership is intended to help people affected by cancer, patient advocates, researchers, and health care providers learn from one another through inclusive conversations and to influence the development of cancer science and cancer care by integrating patient experiences at all levels.

NCI Early-Stage Surgeon Scientist Program

The NCI Early-Stage Surgeon Scientist Program (ESSP) is designed to train surgeon-scientists and retain them in cancer research by supporting a program focused on cancer-related disease and basic and translational research. This program aims to bring together surgeon-scientists from across the United States and assemble groups of surgeons that will be trained together for up to 3 years.

DCEG Strategic Plan

NCI’s Division of Cancer Epidemiology and Genetics (DCEG) lays out the division’s research priorities and objectives in its strategic plan. DCEG envisions a future of epidemiology that embraces the potential of new and emerging analytic technologies, exposures, and data sources.

DCEG Mentorship Stories

DCEG scientists have a longstanding tradition of mentoring young researchers working to uncover the genetic and environmental causes of cancer and the means to prevent it. This post shares the stories of several scientists from DCEG’s Integrative Tumor Epidemiology Branch (ITEB), including that of Branch Chief Gretchen Gierach, Ph.D.

The post is the second installment of the Mentorship at DCEG: A Tradition of Excellence series.

Video: The Frederick National Laboratory for Cancer Research: A Shared National Resource

The NCI-affiliated Frederick National Laboratory for Cancer Research (FNLCR) is the only Federally Funded Research and Development Center devoted to biomedical research. FNLCR operates as a shared national resource, collaborating with public and private partners to speed delivery of new therapies and prevention agents. The lab also conducts basic, translational, and preclinical research and development in cancer and AIDS.

Video: Patients as Partners in Discovery and Progress

This video commemorating the National Cancer Act of 1971 explains how people living with cancer, their caregivers, and survivors play a vital role in understanding and treating cancer and are helping to realize the promise of precision medicine. 

News Release: Blood Test to Detect Cancers Early in People with NF1

Some people with the inherited condition neurofibromatosis type 1 (NF1) develop benign tumors, called plexiform neurofibromas, that grow along nerves. These tumors can sometimes turn into an aggressive cancer called malignant peripheral nerve sheath tumor, but determining whether this change has occurred involves tests that can be painful or inaccurate. NCI scientists have developed a blood test that could one day offer a highly sensitive and inexpensive approach to detect this transformation early in people with NF1. The blood test could also help doctors monitor how well patients are responding to treatment for their cancer.

Advances in Kidney Cancer Research

This new page highlights some of the latest research in kidney cancer, including clinical advances that may soon translate into improved care, NCI-supported programs that are fueling progress, and research findings from recent studies.

New Information on Types of Cancer Treatment

These updated pages explain various methods of treating cancer and which cancers each method is used to treat. Each page discusses how the treatment works, benefits and drawbacks, and possible side effects.

•    Cryosurgery
•    Hyperthermia Therapy
•    Laser Treatment
•    Photodynamic Therapy

Screening Tests to Detect Colorectal Cancer and Polyps

This updated page explains risk factors for colorectal cancer, screening tests that can find it early, and guidelines for who should have screening tests and when.

Cancer Therapy Interactions with Foods and Dietary Supplements

Commonly consumed food and dietary supplements can affect how some cancer therapies work. This new page, part of NCI’s PDQ cancer information collection, provides answers to common questions about a variety of foods and dietary supplements and how they may interact with cancer therapy.



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer that’s not spread elsewhere in the body. “Today’s results are the...

New Combination of Old Drugs Improves Survival in Patients with Prostate Cancer [ESMO Congress 2021 Press Release]

LBA4_PR - Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men...

Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO Congress 2021 Press Release]

LBA2_PR - Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase 3 KEYNOTE-826 study N. Colombo1, C....

Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App

Jessica Baladad has had a long history with self-examinations after a breast cancer scare in her early 20s. This habit helped save her life,...

Extended Adjuvant Treatment with Letrozole Results in Longer Survival in Postmenopausal Patients with Breast Cancer

According to results from a prospective, open-label, phase III study conducted in 69 Italian hospitals within the Gruppo Italiano Mammella among the postmenopausal patients...

Foodie Fridays: Apple Bok Choy Salad

While the temps may still be in the 80’s, apple season is upon us! Give this Apple Bok Choy salad a try!  It is...